HCM
BIIB icon

Hilton Capital Management’s Biogen BIIB Stock Holding History

Hilton Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15
Closed -$3K – 138
2019
Q3 		$3K Hold
15
– – ﹤0.01% 299
2019
Q2 		$4K Hold
15
– – ﹤0.01% 329
2019
Q1 		$4K Hold
15
– – ﹤0.01% 325
2018
Q4 		$5K Hold
15
– – ﹤0.01% 296
2018
Q3 		$5K Sell
15
-3
-17% -$1.03K ﹤0.01% 296
2018
Q2 		$5K Buy
+18
New +$5.06K ﹤0.01% 326

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hilton Capital Management's BIIB Position: Q4 2019 in Review

Hilton Capital Management sold out of Biogen (BIIB) in Q4 2019, closing a stake of 15 shares — an estimated $3K sold.

Hilton Capital Management first reported a position in BIIB in Q2 2018 and held it in 6 quarters. The position peaked at $5K in Q4 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Hilton Capital Management reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Hilton Capital Management sold 15 Biogen shares in Q4 2019, an estimated $3K.
  • Hilton Capital Management first reported a position in Biogen in Q2 2018 and held it in 6 quarters.
  • Hilton Capital Management's Biogen position peaked at $5K in Q4 2018.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Hilton Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.